Literature DB >> 12594334

RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription.

Qing Ge1, Michael T McManus, Tam Nguyen, Ching-Hung Shen, Phillip A Sharp, Herman N Eisen, Jianzhu Chen.   

Abstract

Influenza A virus causes widespread infection in the human respiratory tract, but existing vaccines and drug therapy are of limited value. Here we show that short interfering RNAs (siRNAs) specific for conserved regions of the viral genome can potently inhibit influenza virus production in both cell lines and embryonated chicken eggs. The inhibition depends on the presence of a functional antisense strand in the siRNA duplex, suggesting that viral mRNA is the target of RNA interference. However, siRNA specific for nucleocapsid (NP) or a component of the RNA transcriptase (PA) abolished the accumulation of not only the corresponding mRNA but also virion RNA and its complementary RNA. These siRNAs also broadly inhibited the accumulation of other viral, but not cellular, RNAs. The findings reveal that newly synthesized NP and PA proteins are required for influenza virus transcription and replication and provide a basis for the development of siRNAs as prophylaxis and therapy for influenza infection in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594334      PMCID: PMC151407          DOI: 10.1073/pnas.0437841100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  RNA silencing.

Authors:  David Baulcombe
Journal:  Curr Biol       Date:  2002-02-05       Impact factor: 10.834

Review 2.  Antisense-RNA regulation and RNA interference.

Authors:  Sabine Brantl
Journal:  Biochim Biophys Acta       Date:  2002-05-03

3.  siRNA-directed inhibition of HIV-1 infection.

Authors:  Carl D Novina; Michael F Murray; Derek M Dykxhoorn; Paul J Beresford; Jonathan Riess; Sang-Kyung Lee; Ronald G Collman; Judy Lieberman; Premlata Shankar; Phillip A Sharp
Journal:  Nat Med       Date:  2002-06-03       Impact factor: 53.440

4.  Short interfering RNA confers intracellular antiviral immunity in human cells.

Authors:  Leonid Gitlin; Sveta Karelsky; Raul Andino
Journal:  Nature       Date:  2002-06-26       Impact factor: 49.962

Review 5.  Gene silencing in mammals by small interfering RNAs.

Authors:  Michael T McManus; Phillip A Sharp
Journal:  Nat Rev Genet       Date:  2002-10       Impact factor: 53.242

Review 6.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

Review 7.  Molecular mechanisms of variation in influenza viruses.

Authors:  R G Webster; W G Laver; G M Air; G C Schild
Journal:  Nature       Date:  1982-03-11       Impact factor: 49.962

8.  Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique.

Authors:  Mee-Jung Kim; Anita Ghate Latham; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

9.  Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses.

Authors:  V Bitko; S Barik
Journal:  BMC Microbiol       Date:  2001-12-20       Impact factor: 3.605

10.  Modulation of HIV-1 replication by RNA interference.

Authors:  Jean-Marc Jacque; Karine Triques; Mario Stevenson
Journal:  Nature       Date:  2002-06-26       Impact factor: 69.504

View more
  185 in total

Review 1.  RNA interference and mRNA silencing, 2004: how far will they reach?

Authors:  Thoru Pederson
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

Review 2.  RNA interference: antiviral weapon and beyond.

Authors:  Quan-Chu Wang; Qing-He Nie; Zhi-Hua Feng
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 3.  RNA interference.

Authors:  Julian Downward
Journal:  BMJ       Date:  2004-05-22

Review 4.  Pharmaceutical prospects for RNA interference.

Authors:  Raymond M Schiffelers; Martin C Woodle; Puthupparampil Scaria
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

5.  Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA.

Authors:  Eiryo Kawakami; Tokiko Watanabe; Ken Fujii; Hideo Goto; Shinji Watanabe; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol Methods       Date:  2010-12-24       Impact factor: 2.014

6.  A genome wide RNA interference screening method to identify host factors that modulate influenza A virus replication.

Authors:  Christopher R Chin; Abraham L Brass
Journal:  Methods       Date:  2012-10-02       Impact factor: 3.608

7.  Drosha as an interferon-independent antiviral factor.

Authors:  Jillian S Shapiro; Sonja Schmid; Lauren C Aguado; Leah R Sabin; Ari Yasunaga; Jaehee V Shim; David Sachs; Sara Cherry; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Ana B Sánchez; Mar Perez; Tatjana Cornu; Juan Carlos de la Torre
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Identification of PTCH1 requirement for influenza virus using random homozygous gene perturbation.

Authors:  Wu-Bo Li; Jie Zhu; Brit Hart; Baoquan Sui; Ke Weng; Shaojing Chang; Rebecca Geiger; Montserrat Torremorell; Alan Mileham; Christy Gladney; Martha A Mellancamp; Limin Li; Abdul Yunus; Michael Goldblatt; Michael S Kinch
Journal:  Am J Transl Res       Date:  2009-04-12       Impact factor: 4.060

10.  Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.

Authors:  Alexander Karlas; Nikolaus Machuy; Yujin Shin; Klaus-Peter Pleissner; Anita Artarini; Dagmar Heuer; Daniel Becker; Hany Khalil; Lesley A Ogilvie; Simone Hess; André P Mäurer; Elke Müller; Thorsten Wolff; Thomas Rudel; Thomas F Meyer
Journal:  Nature       Date:  2010-01-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.